White label – Pompe disease - ClinicalTrials.eu

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Not recruiting

3 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Luspatercept
- Sodium Chloride
+6
Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated Drugs:
+3
Study on Early Ablation and Use of Amiodarone, Beta-Blockers, or Sotalol for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

Not recruiting

3 1 1 1
Investigated Diseases:
- Atrial fibrillation
Investigated Drugs:
Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

4 1
Investigated Diseases:
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Bexotegrast
+5
Study on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

2 1
Investigated Diseases:
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Ltp001
Study of Futibatinib with Pembrolizumab and Chemotherapy for Patients with Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study of Abemaciclib, Irinotecan, and Temozolomide for Patients with Relapsed or Refractory Ewing’s Sarcoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Ewing’s sarcoma
Investigated Drugs:
Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated Drugs:
- Guselkumab
+2
Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Not recruiting

4 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Imatinib
+8
Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Not recruiting

3 1
Investigated Diseases:
- Hypertrophic cardiomyopathy
Investigated Drugs:
- Aficamten
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies